Camarda Financial Advisors, LLC Novartis Ag Transaction History

Camarda Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $28,570 - $31,482	-334 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$75.4 - $92.8 $2,865 - $3,526	-38 Reduced 10.22%	334 $30,000
Q1 2019 Apr 25, 2019	BUY	$75.32 - $86.15 $28,019 - $32,047	372 New	372 $36,000
Q4 2017 Feb 07, 2018	SELL	$72.33 - $77.64 $24,881 - $26,708	-344 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$74.14 - $77.27 $25,504 - $26,580	344	344 $30,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Camarda Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Camarda Financial Advisors, LLC with notifications on news.